| Model Number |
EVD35-06-150-120 |
| Medical Device Problem Code |
Material Deformation (2976)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/24/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that an attempt was made to use 2 everflex entrust stents to treat a fibrous lesion in the right proximal mid superficial femoral artery.Degree of calcification was minimal.Artery/vein diameter was 4.5-5.5mm.A terumo 5fr destination was used.A black sion.014 was used.Embolic protection was not used.The first stents nosecone tip detached in vivo within sheath.It did not break off, it separated.Detached component was safely removed from the patient.The second stent deformed with stent/struts deformed in vivo during positioning.There was no patient injury but the stent elongated and had to be snared out.The stent was 500mm, elongated but intact.A new everflex entrust was used to complete the procedure without issue.
|
| |
|
Additional Manufacturer Narrative
|
|
Lot# provided medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis:.The device was returned dismantled.The device was identified from the strain relief.Due to the condition of the returned device, no further testing could be performed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|